Liposome: method of preparation, advantages, evaluation and its application
Keywords:Liposome, Controlled, Targeted drug delivery system, Classification, Methods
Notable research in drug delivery started in 1950’s with the advent of polyclonal antitumor antibodies developed for targeting. Bangham et. Al. discovered liposomes in early 1960’s. In this review article we are discussing about the liposome, methods of the liposome preparation advantages and their different application of the liposome. Liposomes are artificially prepared vesicles made of lipid bilayer. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases. Liposome is used for the targeted drug delivery system and increase the bioavailability and half life of the any drugs. Liposomes are surfactants, sphingolipids, glycol-lipids, long chain fatty acids and even membrane proteins and drug molecules or it is also called vesicular system. Liposomes have been extensively investigated for drug delivery, drug targeting, controlled release and increased solubility.
Madhav NS, Ojha MA, Saini A. A platform for liposomal drug delivery.2015; 3(1):1-6.
Anwekar H, Patel S, Singhai AK. International Journal of Pharmacy & Life Sciences (IJPLS). 2011; 2(7):945-51.
Thulasiramaraju TV, Babu AS, Arunachalam A, Prathap M, Srikanth S, Sivaiah P. Liposome: A novel drug delivery system. International Journal of Biopharmacuties 2012; 2229:7499.
Shashi K, Satinder K, Bharat P. A complete review on: Liposome. International Research Journal of Pharmacy. 2012; 3(7):10-6.
Dua JS, Rana AC, Bhandari AK. Liposome: methods of preparation and applications. International Journal Pharmaceutical Studies Research. 2012; 3:14-20.
Tapaswi D. Liposomes as a potential drug delivery system: A Review. International Research Journal of Pharmacy.2013; 4(1).1-7.
Shivhare UD, Ambulkar DU, Mathur VB, Bhusari KP, Godbole MD. Formulation and evaluation of pentoxifylline liposome formulation. Digest Journal Nanomaterials and Bio structures. 2009 4(4):857-62.
Riaz M. “Review : liposome preparation methods,” Pakistan Journal Pharmaceutical Science 1996;19, 65-77
Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, Samiei M, Kouhi M, Nejati-Koshki K. Liposome: Classification, Preparation, and Applications. Nanoscale Research Letters. 2013; 8(1):102.
Jain N.K. “Controller and Novel Drug Delivery” CBS Publisher and Distributors, New Delhi. 2009; 1; 278-283.
Saraswathi Marripati, K. Umasankar.” A Review on Liposome” International Journal of Research in Pharmaceutical and Nano Sciences. 2014; 3(3), 159 - 169.
Kumar A, Badde S, “Development and characterization of liposomal drug delivery system for nimesulide” International Journal Pharmacy and Pharmaceutical Sciences, 2010;3: 87- 89.
Nidhal KM, Athmar DH “Preparation and evaluation of salbutamol liposomal suspension using chloroform film method” Mustansiriya Medical Journal, 2012,11 (2): 39-44.
Da Costa CA, Moraes ÂM. Encapsulation of 5-fluorouracil in liposome for topical administration. Acta Scientiarum Technol Maringá. 2003; 25:53-61.
Yamauchi M, Tsutsumi K, Abe M, Uosaki Y, Nakakura M, Aoki N. Release of drugs from liposomes varies with particle size. Biological and Pharmaceutical Bulletin. 2007; 30(5):963-6.
Caponigro F, Cornelia P, Budillon A, Bryce J, Avallone A, De Rosa V, Ionna F, and Cornelia G. Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer. Annals of oncology. 2000; 11(3):339-42.
Kataria S, Sandhu P, Bilandi A, Akanksha M, Kapoor B, Seth GL, Bihani SD: Stealth liposomes: a review. International Journal Research Ayurveda and Pharmacy 2011, 2(5):1534–1538.
Dapergolas G, Gregoriadis G. Hypoglycaemic effect of liposome-entrapped insulin administered intragastrically into rats. The Lancet. 1976; 308:824-7.
Betz G, Aeppli A, Menshutina N, Leuenberger H. In vivo comparison of various liposome formulations for cosmetic application. International journal of pharmaceutics. 2005; 296(1):44-54.
Müller-Goymann CC. Physicochemical characterization of colloidal drug delivery systems such as reverse micelles, vesicles, liquid crystals and nanoparticles for topical administration. European Journal of Pharmaceutics and Biopharmaceutics. 2004; 58(2):343-56.
Lautenschläger H. Liposomes, Handbook of Cosmetic Science and Technology (AO Barel, M. Paye and HI Maibach), 155-163.
Patravale VB, Mandawgade SD. Novel cosmetic delivery systems: an application update. International journal of cosmetic science. 2008; 30(1):19-33.
Taylor TM, Weiss J, Davidson PM, Bruce BD. Liposomal nanocapsules in food science and agriculture. Critical Reviews in Food Science and Nutrition. 2005; 45(7-8):587-605.
Reza Mozafari M, Johnson C, Hatziantoniou S, Demetzos C. Nanoliposomes and their applications in food nanotechnology. Journal of liposome research. 2008; 18(4):309-27.
Gabizon A. Liposomes as a drug delivery system in cancer chemotherapy. Horizons in biochemistry and biophysics. 1989; 9:185.
Storm G, Roerdink FH, Steerenberg PA, De Jong WH, Crommelin DJ. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer research. 1987; 47(13):3366-72.
Lasic DD, Martin FJ, Gabizon A, Huang SK, Papahadjopoulos D. Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochemical et Biophysical Acta (BBA)-Bio membranes. 1991; 1070(1):187-92.
Banerjee R, Tyagi P, Li S, Huang L. Anis amide‐targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells. International journal of cancer. 2004; 112(4):693-700.
Parthasarathy R, Sacks PG, Harris D, Brock H, Mehta K. Interaction of liposome-associated all-trans-retinoic acid with squamous carcinoma cells. Cancer chemotherapy and pharmacology. 1994; 34(6):527-34.
Mehta K, Sadeghi T, McQueen T, Lopez-Berestein G. Liposome encapsulation circumvents the hepatic clearance mechanisms of all-trans-retinoic acid. Leukemia research. 1994; 18(8):587-96.
Remington “The Science and Practice of Pharmacy”, vol. 1,21st edition, B.I publishers Pvt. Ltd, 314-316.
Kaur L, Kaur P and Khan MU Liposome As A Drug Carrier – A Review”International Journal Research Pharmacy and Chemistry 2013 (3)1
Hamilton R.L., Guo L.S.S.” Liposome preparation methods” J Clin Bio-chem Nut 1984, 7:175
Bangham A D, Horne R W. “Negative Staining of Phospholipids and Their Structural Modification by Surface-Active Agents As Observed in the Electron Microscope” Journal of Molecular Biology, 8(5), 1964, 660-668.
Barani H, Montazer M. “A review on applications of liposome in textile processing” Journal of liposome research, 18(3), 2008, 249- 262.
Mansoori M.A, Agrawal S, “A Review on Liposome” International Journal Advanced Research Pharmaceutical and Bio-sciences, 2012; 2 (4):453-464.
Abolfazl A., Rogaie R.S., Nano review of Liposome: classification, preparation and applications” Nanoscale Research Letters 2013, 8:102.
Priyanka R Kulkarni, Jaydeep D Yadav, “Liposome A Novel Drug Delivery System” International Journal of Current Pharmaceutical Research Volume 3, Issue 2, 2011.
J.S.Dua1, Prof.A.C.Rana, “Liposome: Methods of Preparation and Applications” International Journal of Pharmaceutical Studies and Research.
Dr. N. V. Sateesh Madhav, “A platform for liposomal drug delivery” IJPDA Vol: 3; Issue: 1
Vyas S.P, Khar K.R. “Targeted and Controlled Drug Delivery” CBS Publisher and Distributors, New Delhi. 2002; 1; 181-187.
How to Cite
Copyright (c) 2020 Bhupendra Pradhan, Narendra Kumar, Suman Saha, Amit Roy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
In submitting an article to Journal of Applied Pharmaceutical Research (JOAPR) I certify that:
- I am authorized by my co-authors to enter into these arrangements.
- I warrant, on behalf of myself and my co-authors, that:
- the article is original, has not been formally published in any other peer-reviewed journal, is not under consideration by any other journal and does not infringe any existing copyright or any other third party rights;
- I am/we are the sole author(s) of the article and have full authority to enter into this agreement and in granting rights to JOAPR are not in breach of any other obligation;
- the article contains nothing that is unlawful, libellous, or which would, if published, constitute a breach of contract or of confidence or of commitment given to secrecy;
- I/we have taken due care to ensure the integrity of the article. To my/our - and currently accepted scientific - knowledge all statements contained in it purporting to be facts are true and any formula or instruction contained in the article will not, if followed accurately, cause any injury, illness or damage to the user.
- I, and all co-authors, agree that the article, if editorially accepted for publication, shall be licensed under the Creative Commons Attribution-NonCommercial 4.0 International License
- I, and all co-authors, agree that, if the article is editorially accepted for publication in Journal of Applied Pharmaceutical Research (JOAPR) data included in the article shall be made available under the Creative Commons 1.0 Public Domain Dedication waiver, unless otherwise stated. For the avoidance of doubt it is stated that sections 1, 2, and 3 of this license agreement shall apply and prevail.